杨晓达教授团队在基于钒活性基团的蛋白磷酸酶特异性抑制剂及其生物效应方面取得重要进展

中国药学(英文版) ›› 2021, Vol. 30 ›› Issue (11): 932-933.

杨晓达教授团队在基于钒活性基团的蛋白磷酸酶特异性抑制剂及其生物效应方面取得重要进展

北京大学药学院天然药物及仿生药物国家重点实验室

北京大学药学院天然药物及仿生药物国家重点实验室

收稿日期:2021-11-10 修回日期:2021-11-15 接受日期:2021-11-15 出版日期:2021-11-28 发布日期:2021-11-30

The group of Professor Xiaoda Yang has made important progress in protein phosphatase inhibitors based on vanadium active groups

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2021-11-10 Revised:2021-11-15 Accepted:2021-11-15 Online:2021-11-28 Published:2021-11-30

摘要/Abstract

摘要：

2021年10月27日, 北京大学药学院天然药物及仿生药物国家重点实验室杨晓达团队在国际著名学术期刊《Advanced Functional Materials》(IF = 18.808)在线发表了题为“Convergent Protein Phosphatase Inhibitor Design for PTP1B and TCPTP: Exchangeable Vanadium Coordination Complexes on Graphene Quantum Dots”的研究工作。

关键词: 蛋白磷酸酶特异性抑制剂

Abstract: The group of Professor Xiaoda Yang has made important progress in protein phosphatase inhibitors based on vanadium active groups.

Key words: Protein phosphatase inhibitors

Supporting:

北京大学药学院天然药物及仿生药物国家重点实验室. 杨晓达教授团队在基于钒活性基团的蛋白磷酸酶特异性抑制剂及其生物效应方面取得重要进展[J]. 中国药学(英文版), 2021, 30(11): 932-933.

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The group of Professor Xiaoda Yang has made important progress in protein phosphatase inhibitors based on vanadium active groups[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(11): 932-933.